Dai Okemoto, Daisuke Kotani, Yuto Kubo, Kazuma Sato, Masaki Nakamura, Shingo Sakashita, Saori Mishima, Kohei Shitara, Takashi Kojima, Takeo Fujita. "A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps471